Bosutinib For Autosomal Dominant Polycystic Kidney Disease

Clinical trial NCT01233869 · COMPLETED

Trial details

NCT number: NCT01233869
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Polycystic Kidney, Autosomal Dominant

Start date: 2010-12-01
Primary completion: 2014-07-01
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.